Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary

Richard E Waters1, Kanwar P Singh, Matthew T Roe

  • 1Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.

Insights

Transferring patients with ST-segment elevation myocardial infarction (STEMI) to specialized centers for primary percutaneous coronary intervention (PCI) improves outcomes. System-wide changes are needed to overcome barriers and optimize STEMI care networks.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Healthcare Systems

Background:

  • Acute ST-segment elevation myocardial infarction (STEMI) treatment is evolving.
  • Primary percutaneous coronary intervention (PCI) offers benefits over fibrinolytic therapy for STEMI.
  • Extending PCI to community hospitals without interventional capabilities is a key focus.

Purpose of the Study:

  • To evaluate the effectiveness of transferring STEMI patients to tertiary centers for primary PCI.
  • To identify obstacles hindering the adoption of patient-transfer strategies in the U.S.
  • To propose a framework for developing integrated acute myocardial infarction (AMI) care networks.

Main Methods:

  • Review of randomized clinical trials comparing primary PCI transfer versus in-hospital fibrinolysis.
  • Analysis of challenges in implementing STEMI patient transfer protocols.
  • Discussion of system-wide changes analogous to trauma networks for AMI care.

Main Results:

  • Randomized trials demonstrate superior outcomes with primary PCI at tertiary centers compared to fibrinolysis at community hospitals.
  • Significant barriers to patient transfer include distance, lack of integrated emergency medical services, and limited experience with centralized care.
  • Potent pharmacologic reperfusion regimens may enhance the benefits of pre-PCI transfer.

Conclusions:

  • Patient transfer strategies for STEMI can improve outcomes but face implementation hurdles in the U.S.
  • Developing integrated AMI care networks with standardized protocols is crucial for quality assurance and future research.
  • System-wide changes are necessary to optimize early invasive care and reduce STEMI morbidity and mortality.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...